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Introduction to Bioethics Special
Supplement V: Ethical Issues in
Genomic Testing of Children
John D. Lantos, MD

Next-generation genome sequencing of children is one of the most promising and most
challenging new technologies in pediatrics. On the one hand, it offers the hope that we will
be able to diagnose rare conditions that were previously impossible to diagnose, which,
in turn, might lead to new treatments. On the other hand, the technology for sequencing
presents daunting problems of interpretation. It is problematic to conduct the research
necessary to characterize the pathogenicity of those variants at the same time that we are
using them to guide the clinical care of children who have complex medical problems. It is
difficult to know how parents will deal with predictive genomic information about their
children. It is also difficult to know whether genome sequencing will complement or replace
more traditional methods of newborn screening. This special supplement to Pediatrics
presents some early reports from researchers who are exploring both the technical issues as
well as the ethical, legal, and social issues that arise when we perform genomic sequencing
on newborns.
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SUPPLEMENT ARTICLE

Whole-genome sequencing of
children is one of the most promising
and one of the most disturbing new
technologies in pediatrics. On the one
hand, it offers the hope that we will
be able to diagnose rare conditions
that were previously impossible to
diagnose, which, in turn, might lead
to new treatments. On the other
hand, the technology for sequencing
presents daunting problems of
interpretation. Among our 6 billion
base pairs, there are millions of
variants of unknown significance. It
is difficult to conduct the research
necessary to characterize the
pathogenicity of those variants at the
same time that we are using them
to guide the clinical care of children
who have complex medical problems.
In August 2012, the Eunice Kennedy
Shriver National Institute of Child
Health and Human Development
and the National Human Genome
Research Institute issued a call
for project proposals that would
be designed “…to explore the
implications, challenges and
opportunities associated with the
possible use of genomic sequence
information in the newborn
period.” They favored projects that
looked at the analysis of genomic
data sets; the use of DNA-based
analyses for newborn screening;
and research related to ethical,
legal, and social implications of
the possible implementation of
genomic sequencing of newborns.
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Eventually, they funded projects at
4 sites: Children’s Mercy Hospital
(CMH) in Kansas City, University of
California–San Francisco (UCSF),
University of North Carolina (UNC),
and a collaborative project between
Harvard University and Baylor
College of Medicine (Harvard/
Baylor).

Each of the projects has a different
focus. The project at CMH focuses
on the use of next-generation
sequencing to diagnose critically ill
newborns in the NICU. The Harvard/
Baylor project is enrolling critically ill
newborns but also includes a control
group of healthy newborns. UCSF is
comparing the use of next-generation
sequencing with the traditional
methods used for newborn metabolic
screening and exploring the attitudes
of parents and physicians regarding
this form of testing. The UNC
project focuses on helping parents
understand the type of results such
testing might produce and assisting
physicians to decide which results
should be returned to parents. Each
project has technical, clinical, and
bioethical components.
This special supplement to Pediatrics
is a first look at some of the ethical
issues the investigators have
encountered in these projects. We
begin with an article by Thiffault and
Lantos that explains the technology
and some practical aspects of
interpreting the massive amount
of data that are generated by any

analysis of a whole-genome or a
whole exome. The second article, by
King and Smith, analyzes the legal
framework for newborn screening
programs and speculates about the
implications of genome sequencing
for those programs. Lewis and
colleagues from UNC discuss the
development of a decision aid tool
that is designed to help parents
consider the type of information that
they would like to receive about their
infants. Frankel, Pereira, and McGuire
of the Harvard/Baylor project
discuss what we know—and what we
hope to learn—about the potential
psychosocial risks of genome
screening of newborns. In a related
article, Waisbren and colleagues from
Harvard present data on psychosocial
factors that influence parents’
interest in genomic screening of
their children. Joseph and colleagues
from UCSF present the preliminary
results of focus groups that they
have conducted with diverse sets of
pregnant women in the San Francisco
Bay area about their knowledge,
attitudes, and beliefs regarding
genomic testing. Finally, Deem, from
CMH, analyzes some implications of
genomic screening and our attitudes
about children with disabilities.
Taken together, these articles
represent an early report from
programs that are starting to
explore the clinical uses of genome
sequencing and the ethical, legal, and
psychosocial issues that have arisen.
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